New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 8, 2014
07:23 EDTABT, UHS, CYH, ALXN, AUXL, BLUE, OVAS, CAH, BAYRY, ANACDeutsche Bank to hold a conference
39th Annual Healthcare Conference is being held in Boston on May 7-8 with webcasted company presentations to begin on May 8 at 8 am; not all company presentations may be webcasted. Webcast Link
News For OVAS;CYH;ANAC;BLUE;UHS;BAYRY;AUXL;ABT;CAH;ALXN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 17, 2015
07:45 EDTBLUEbluebird bio price target raised to $150 from $117 at JPMorgan
Subscribe for More Information
April 16, 2015
12:19 EDTBAYRYBayer downgraded to Equal Weight from Overweight at Morgan Stanley
Subscribe for More Information
07:05 EDTCAHNovaBay signs distribution agremeent with AmerisourceBergen
Subscribe for More Information
April 15, 2015
10:36 EDTCAHBofA/Merrill U.S. credit analysts hold an analyst/industry conference call
Subscribe for More Information
08:40 EDTCYH, UHSHospital stocks rise in pre-market after HCA boosts 2015 guidance
Subscribe for More Information
07:41 EDTBAYRY, ABTEBD Group to hold a forum
ChinaBio Partnering Forum 2015 is being held in Shanghai, China on April 15-16.
April 14, 2015
09:06 EDTABTAbbott and Sekisui announce collaboration for coagulation testing
Abbott and Sekisui announce an agreement to offer coagulation testing solutions for laboratories worldwide. Coagulation tests measure a person's blood clotting ability, which can help doctors assess risks of excessive bleeding or developing clots. Under the agreement, Abbott will be the exclusive distributor of Sekisui's new CP3000 coagulation instrument in the United States, Europe and other regions that recognize CE Mark.
April 13, 2015
14:07 EDTCAHEarnings Watch: Johnson & Johnson shares down slightly since last earnings
Subscribe for More Information
09:13 EDTBLUEbluebird bio has a conference call hosted by JPMorgan
Subscribe for More Information
April 10, 2015
05:28 EDTALXNAlexion receives approval for updates to EU label for Solaris
Subscribe for More Information
April 9, 2015
10:58 EDTOVASOvaScience management to meet with Oppenheimer
Meeting to be held in Boston on April 9 hosted by Oppenheimer
April 8, 2015
07:27 EDTOVASNegative article on OvaScience has inaccuracies, says Oppenheimer
Subscribe for More Information
April 7, 2015
17:38 EDTALXNAlexion CEO Dr. Leonard Bell retired as of March 31
Dr. Leonard Bell, the principal founder and CEO of Alexion Pharmaceuticals retired from Alexion effective March 31, after serving as CEO for twenty-three years. No severance was paid to Dr. Bell in connection with his retirement. On April 1, Alexion entered into a Consulting Agreement and a Letter Agreement with Dr. Bell. Dr. Bell continues to serve as Alexion's Chairman of the Board of Directors.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use